XML 51 R37.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Schedule of Information with Respect to Outstanding and Exercisable Stock Options

The following table summarizes information with respect to all outstanding and exercisable stock options under all of our plans as of December 31, 2021:

 

Options Outstanding

 

 

Options Exercisable

 

Number of

Options

Outstanding

 

 

Weighted Average

Exercise Price

 

 

Weighted Average

Remaining

Contractual Term

(in Years)

 

 

Number

Exercisable

 

 

Weighted

Average

Exercise Price

 

 

64,000

 

 

$

2.82

 

 

 

1.36

 

 

 

64,000

 

 

$

2.82

 

 

106,656

 

 

$

3.93

 

 

 

3.38

 

 

 

106,656

 

 

$

3.93

 

 

108,922

 

 

$

4.60

 

 

 

3.80

 

 

 

108,922

 

 

$

4.60

 

 

23,704

 

 

$

5.90

 

 

 

3.18

 

 

 

23,704

 

 

$

5.90

 

 

105,645

 

 

$

5.96

 

 

 

4.39

 

 

 

105,645

 

 

$

5.96

 

 

73,308

 

 

$

6.60

 

 

 

0.94

 

 

 

73,308

 

 

$

6.60

 

 

105,533

 

 

$

8.30

 

 

 

5.18

 

 

 

105,533

 

 

$

8.30

 

 

72,794

 

 

$

9.94

 

 

 

5.42

 

 

 

72,794

 

 

$

9.94

 

 

236,452

 

 

$

13.80

 

 

 

6.18

 

 

 

171,061

 

 

$

13.80

 

 

98,077

 

 

$

17.91

 

 

 

6.92

 

 

 

98,077

 

 

$

17.91

 

 

995,091

 

 

$

9.02

 

 

 

4.57

 

 

 

929,700

 

 

$

8.68

 

Summary of Total Stock Based Compensation Expense

Stock-Based Compensation Expense. Total stock-based compensation expense for the years ended December 31, 2021, 2020 and 2019 for all types of awards was as follows (dollars in thousands):

 

 

 

December 31,

 

Award Type

 

2021

 

 

2020

 

 

2019

 

Stock options

 

$

464

 

 

$

1,134

 

 

$

1,690

 

Restricted stock units settled in stock

 

 

14,495

 

 

 

12,227

 

 

 

7,569

 

Restricted stock units settled in cash

 

 

-

 

 

 

(240

)

 

 

2,301

 

Total stock-based compensation expense

 

$

14,959

 

 

$

13,121

 

 

$

11,560

 

 

Schedule of Fair Value of Stock Option Award Granted Estimated on Date of Grant Using the Black-Scholes-Merton Option Pricing Model The weighted average fair value per share of stock option awards granted during the year ended December 31, 2019 and assumptions used to value stock options are as follows:

 

 

 

For the Year Ended December 31,

 

 

 

2021 (1)

 

2020 (1)

 

2019

 

Dividend yield

 

NA

 

NA

 

 

-

 

Risk-free interest rate

 

NA

 

NA

 

 

1.6

%

Weighted average volatility

 

NA

 

NA

 

 

62.6

%

Expected life (in years)

 

NA

 

NA

 

 

8.0

 

Weighted average grant date fair value per share of options granted

 

NA

 

NA

 

$

13.78

 

 

(1)

There were no stock options awarded during the years ended December 31, 2021 and 2020.

Restricted Stock Units [Member]  
Schedule of Information with Respect to all Outstanding Restricted Stock

The following table summarizes information with respect to all outstanding restricted stock units to be settled in shares of stock under our plans during the years ended December 31, 2021, 2020 and 2019:

 

 

 

Restricted Stock to be Settled in Shares of Stock

 

 

 

Units

 

 

Weighted

Average

Grant-Date

Fair Value

Per Unit

 

Outstanding as of December 31, 2018

 

 

2,017,477

 

 

$

12.70

 

Granted

 

 

427,488

 

 

 

21.31

 

Vested

 

 

(500,818

)

 

 

6.14

 

Forfeited

 

 

(22,955

)

 

 

11.42

 

Outstanding as of December 31, 2019

 

 

1,921,192

 

 

$

16.34

 

Granted

 

 

534,471

 

 

 

15.45

 

Vested

 

 

(242,515

)

 

 

11.02

 

Forfeited

 

 

(67,098

)

 

 

17.18

 

Outstanding as of December 31, 2020

 

 

2,146,050

 

 

$

16.70

 

Granted

 

 

723,245

 

 

 

11.87

 

Vested

 

 

(1,329,017

)

 

 

16.35

 

Forfeited

 

 

(77,085

)

 

 

11.98

 

Outstanding as of December 31, 2021

 

 

1,463,193

 

 

$

14.87

 

Employee Stock Option [Member]  
Summary of Stock Option Activity

Stock option activity during the years ended December 31, 2021, 2020 and 2019 under our plans was as follows:

 

 

 

Options

 

 

Weighted Average

Exercise Price

 

 

Weighted

Average

Remaining

Contractual

Term

 

 

Aggregate

Intrinsic Value

(in thousands)

 

Outstanding as of December 31, 2018

 

 

2,818,433

 

 

$

9.59

 

 

 

 

 

 

 

 

 

Granted

 

 

41,958

 

 

 

21.29

 

 

 

 

 

 

 

 

 

Exercised

 

 

(258,621

)

 

 

5.76

 

 

 

 

 

 

$

2,902

 

Forfeited

 

 

(8,017

)

 

 

15.39

 

 

 

 

 

 

 

 

 

Cancelled

 

 

(156,144

)

 

 

22.99

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2019

 

 

2,437,609

 

 

$

9.32

 

 

 

 

 

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

Exercised

 

 

(1,040,304

)

 

 

5.18

 

 

 

 

 

 

$

7,615

 

Forfeited

 

 

(8,719

)

 

 

11.79

 

 

 

 

 

 

 

 

 

Cancelled

 

 

(161,512

)

 

 

30.25

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2020

 

 

1,227,074

 

 

$

10.07

 

 

 

 

 

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

Exercised

 

 

(103,407

)

 

 

5.31

 

 

 

 

 

 

$

725

 

Forfeited

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

Cancelled

 

 

(128,576

)

 

 

22.01

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2021

 

 

995,091

 

 

$

9.02

 

 

 

4.57

 

 

$

3,823

 

Exercisable as of December 31, 2021

 

 

929,700

 

 

$

8.68

 

 

 

4.46

 

 

$

3,823